|
Ranbaxy
moves court against NPPA demand for Rs 4.6 crore
Drug major Ranbaxy Laboratories Ltd has moved the Delhi High Court
against the central government, seeking a stay of demand notice
for Rs 4.65 crore slapped by the National Pharmaceuticals Pricing
Authority (NPPA) on account of alleged overcharging of certain formulations
that the company says it does not manufacture.
Dilip
Shah appointed IGPA chairman
The Secretary General of the Indian Pharmaceutical Alliance (IPA)
has been selected as the Chairman of the International Generic Pharmaceutical
Alliance (IGPA).
Drug
majors propose one percent health cess
Domestic drug majors have proposed imposition of a one percent cess
on all heathcare products and services, including retail pharma
sales to subsidise medicines for the low income class.
NPIL
buys 17 percent stake in Canadian firm
City-based Nicholas Piramal India (NPIL) has picked up a 17.1% stake
in BioSyntech, Inc, a Canadian biotechnology company for a consideration
of CAN$6 million. In an announcement to the stock exchange, NPIL
said it has bought 7,500,000 common shares of the company at a price
of CAN$0.8 per share.
HLL’s
Ayush dying a slow death
It’s official, finally. Hindustan Lever (HLL)’s ayurvedic
brand Lever Ayush, launched with high expectations in 2002 is under
review.
Glenmark,
Napo sign pact for novel anti-diarrhoeals
Glenmark Pharmaceuticals and Napo Pharmaceuticals announced a collaboration
agreement for Napo’s proprietary anti-diarrhoeal compound Crofelemer.
Aarti
Drugs bags Rs 200 cr export order
Aarti Drugs Ltd today said it has bagged an export order worth Rs
200 crore for supplying anti-fouling agent.
|
